Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Lundgren

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Diabetologia|October 4, 2022
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in childrenKenney Ng, Vibha Anand, Harry Stavropoulos, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2022
Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 DiabetesZhiguo Li, Riitta Veijola, Eileen Koski, et al.
Nature Communications|March 22, 2022
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectoriesBum Chul Kwon, Vibha Anand, Peter Achenbach, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2020
Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 DiabetesAndrea K Steck, Xiang Liu, Jeffrey P Krischer, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFAMaria Månsson Martinez, Falastin Salami, Helena Elding Larsson, et al.
Diabetologia|January 6, 2021
First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic riskSuzanne Bennett Johnson, Kristian F Lynch, Roswith Roth, et al.
Journal of Immunological Methods|March 31, 2022
Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac diseaseAlexander Lind, Felipe de Jesus Cortez, Anita Ramelius, et al.
Pediatric Diabetes|September 9, 2022
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY childrenFalastin Salami, Roy Tamura, Lu You, et al.
Clinical Diabetes and Endocrinology|January 5, 2022
Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFAMaria Månsson Martinez, Lampros Spiliopoulos, Falastin Salami, et al.
BMJ Open|July 1, 2019
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocolAnette-Gabriele Ziegler, Peter Achenbach, Reinhard Berner, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Diabetologia|October 4, 2022
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in childrenKenney Ng, Vibha Anand, Harry Stavropoulos, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2022
Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 DiabetesZhiguo Li, Riitta Veijola, Eileen Koski, et al.
Nature Communications|March 22, 2022
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectoriesBum Chul Kwon, Vibha Anand, Peter Achenbach, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2020
Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 DiabetesAndrea K Steck, Xiang Liu, Jeffrey P Krischer, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFAMaria Månsson Martinez, Falastin Salami, Helena Elding Larsson, et al.
Diabetologia|January 6, 2021
First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic riskSuzanne Bennett Johnson, Kristian F Lynch, Roswith Roth, et al.
Journal of Immunological Methods|March 31, 2022
Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac diseaseAlexander Lind, Felipe de Jesus Cortez, Anita Ramelius, et al.
Pediatric Diabetes|September 9, 2022
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY childrenFalastin Salami, Roy Tamura, Lu You, et al.
Clinical Diabetes and Endocrinology|January 5, 2022
Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFAMaria Månsson Martinez, Lampros Spiliopoulos, Falastin Salami, et al.
BMJ Open|July 1, 2019
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocolAnette-Gabriele Ziegler, Peter Achenbach, Reinhard Berner, et al.
Pageof 7